Integra Lifesciences Holdings Corp (STU:IL3)
€ 23.8 0.8 (3.48%) Market Cap: 1.83 Bil Enterprise Value: 3.43 Bil PE Ratio: 0 PB Ratio: 1.29 GF Score: 71/100

Integra Lifesciences Holdings Corp at Wells Fargo Virtual Healthcare Conference Transcript

Sep 09, 2021 / 03:20PM GMT
Release Date Price: €62 (-1.59%)
Shagun Singh Chadha

Good morning, everyone. Welcome to the 2021 Wells Fargo Healthcare Conference. I'm Shagun Singh, part of the medical device team at Wells Fargo, and I'm pleased to host our next fireside chat with Integra Life Sciences. Joining us from the company are Carry Anderson, Executive Vice President and Chief Financial Officer; and Mike Beaulieu, Head of Investor Relations. Thank you, everyone, for joining us today.

Questions & Answers

Shagun Singh Chadha;Carrie L. Anderson
Integra LifeSciences Holdings Corporation - Executive VP

So let's dive right in. Let's begin with a discussion of business performance in the first half of '21. So it appears that Integra saw improving trends in the first half, despite the pandemic. If you look at growth in '21 over 2019, it appears that Q1 growth was 3% and it improved to about 4% in Q2. So Carrie, can you just level set us here and discuss the drivers of your performance in the first 6 months of the year? And where is procedure and capital recovery relative to baseline, that is 2019?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot